The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. by Sanchez, Carlos J et al.
UCSF
UC San Francisco Previously Published Works
Title
The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that 
promotes bacterial aggregation in vivo and in biofilms.
Permalink
https://escholarship.org/uc/item/8xw1f4m9
Journal
PLoS pathogens, 6(8)
ISSN
1553-7366
Authors
Sanchez, Carlos J
Shivshankar, Pooja
Stol, Kim
et al.
Publication Date
2010-08-12
DOI
10.1371/journal.ppat.1001044
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The Pneumococcal Serine-Rich Repeat Protein Is an Intra-
Species Bacterial Adhesin That Promotes Bacterial
Aggregation In Vivo and in Biofilms
Carlos J. Sanchez1, Pooja Shivshankar1, Kim Stol2, Samuel Trakhtenbroit1, Paul M. Sullam3, Karin Sauer4,
Peter W. M. Hermans2, Carlos J. Orihuela1*
1Department of Microbiology and Immunology, The University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America, 2 Laboratory of
Pediatric Infectious Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 3Division of Infectious Diseases, San Francisco VA Medical Center
and the University of California, San Francisco, California, United States of America, 4Department of Biological Sciences, Binghamton University, Binghamton, New York,
United States of America
Abstract
The Pneumococcal serine-rich repeat protein (PsrP) is a pathogenicity island encoded adhesin that has been positively
correlated with the ability of Streptococcus pneumoniae to cause invasive disease. Previous studies have shown that PsrP
mediates bacterial attachment to Keratin 10 (K10) on the surface of lung cells through amino acids 273–341 located in the
Basic Region (BR) domain. In this study we determined that the BR domain of PsrP also mediates an intra-species interaction
that promotes the formation of large bacterial aggregates in the nasopharynx and lungs of infected mice as well as in
continuous flow-through models of mature biofilms. Using numerous methods, including complementation of mutants
with BR domain deficient constructs, fluorescent microscopy with Cy3-labeled recombinant (r)BR, Far Western blotting of
bacterial lysates, co-immunoprecipitation with rBR, and growth of biofilms in the presence of antibodies and competitive
peptides, we determined that the BR domain, in particular amino acids 122–166 of PsrP, promoted bacterial aggregation
and that antibodies against the BR domain were neutralizing. Using similar methodologies, we also determined that SraP
and GspB, the Serine-rich repeat proteins (SRRPs) of Staphylococcus aureus and Streptococcus gordonii, respectively, also
promoted bacterial aggregation and that their Non-repeat domains bound to their respective SRRPs. This is the first report
to show the presence of biofilm-like structures in the lungs of animals infected with S. pneumoniae and show that SRRPs
have dual roles as host and bacterial adhesins. These studies suggest that recombinant Non-repeat domains of SRRPs (i.e. BR
for S. pneumoniae) may be useful as vaccine antigens to protect against Gram-positive bacteria that cause infection.
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Introduction
Streptococcus pneumoniae is a leading cause of otitis media (OM),
community-acquired pneumonia, sepsis and meningitis. Primarily
a commensal, S. pneumoniae typically colonizes the nasopharynx
asymptomatically, however in susceptible individuals such as
infants, the elderly, persons who are immunocompromised, and
those with sickle cell anemia, the pneumococcus is often able to
cause opportunistic diseases [1,2,3,4]. Worldwide, S. pneumoniae is
responsible for up to 14.5 million episodes of invasive pneumo-
coccal disease (IPD) and 11% of all deaths in children [5,6]. In the
elderly the mortality-rate associated with IPD can exceed 20% and
for those in nursing homes may be as high as 40% [7]. Thus, the
pneumococcus has been and remains a major cause of morbidity
and mortality.
psrP-secY2A2 is a S. pneumoniae pathogenicity island whose
presence has been positively correlated with the ability to cause
human disease [8]. Analyses of the published S. pneumoniae
genomes has demonstrated that psrP-secY2A2 is present and
conserved in a number of globally distributed invasive clones, in
particular those belonging to serotypes not covered by the
heptavalent conjugate vaccine [9]. To date, numerous studies
have shown that deletion of genes within psrP-secY2A2 attenuated
the ability of S. pneumoniae to cause disease in mice. psrP-secY2A2
mutants were shown to be unable to attach to lung cells, establish
lower respiratory tract infection, and were delayed in their ability
to enter the bloodstream from the lungs. Importantly, the same
studies found that psrP-secY2A2 did not play an important role
during nasopharyngeal colonization or during sepsis following
intraperitoneal challenge [10,11,12,13]. Thus psrP-secY2A2 is
currently understood to be a lung-specific virulence determinant.
In TIGR4, a virulent serotype 4 laboratory strain, psrP-secY2A2
is 37-kb in length and encodes 18 proteins. These include the
Pneumococcal serine-rich repeat protein (PsrP), which is a lung
cell adhesin, 10 putative glycosyltranferases, and 7 proteins
homologous to components of an accessory Sec translocase [14].
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To date, the latter 17 genes remain uncharacterized; however,
based on their homology to genes found within the Serine-rich
repeat protein (SRRP) locus of Streptococcus gordonii, the encoded
proteins are putatively responsible for the intracellular glycosyla-
tion of PsrP and for its transport to the bacterial surface
[8,15,16,17,18]. PsrP in TIGR4 is composed of 4,776 amino
acids, has been confirmed to be glycosylated, and separates at an
apparent molecular mass of 2,300 kDa on an agarose gel [13]. It is
one of the largest bacterial proteins known. PsrP is organized into
multiple domains including a cleavable N-terminal signal peptide,
a small serine-rich repeat region (SRR1), a unique non-repeat
region (NR), followed by a second extremely long serine-rich
region (SRR2), and a C-terminal cell wall anchor domain
containing an LPXTG motif (Figure 1A). The SRR1 and SRR2
domains of PsrP are composed of 8 and 539 serine-rich repeats
(SRR) of the amino acid sequence SAS[A/E/V]SAS[T/I],
respectively, and are the domains believed to be glycosylated.
The NR domain of PsrP has a predicted pI value of 9.9, for this
reason it is called the Basic Region (BR) domain.
S. pneumoniae is surrounded by a polysaccharide capsule that
protects the bacteria from phagocytosis but also inhibits adhesion
to epithelial cells [19]. Based on the size and domain organization
of PsrP we have previously hypothesized that the extremely long
SRR2 domain serves to extend the BR domain through the
capsular polysaccharide to mediate lung cell adhesion (Figure 1B)
[12,13]. Consistent with this model, we have previously shown that
PsrP is expressed on the bacterial surface, that the BR domain, in
particular amino acids 273–341, was responsible for PsrP-
mediated adhesion to Keratin 10 (K10) on lung cells, and that
complementation of psrP deficient mutants with a truncated
version of the protein (having only 33 SRRs in its SRR2 domain)
restored the ability of uncapsulated but not capsulated PsrP
mutants to adhere to A549 cells, a human type II pneumocyte cell
line [13].
It is now recognized that biofilms play an important role during
infectious diseases. Briefly, bacteria in biofilms are more resistant
to host-defense mechanisms including phagocytosis and serve as a
recalcitrant source of bacteria during antimicrobial therapy
[20,21]. For S. pneumoniae, pneumococcal biofilms have been
shown to occur in the middle ears of children with chronic otitis
media and is thought to contribute to its refractory nature [22].
Likewise, biofilms have been detected in the nasopharynx of
infected chinchillas [23]. However, until now biofilm structures
have not been described in the lungs during pneumococcal
pneumonia. This is in contrast to other respiratory tract
pathogens, such as Pseudomonas aeruginosa and Bordatella pertussis,
for which in vivo biofilm production is now recognized to be an
important pathogenic mechanism [21]. Herein, we demonstrate
for the first time that S. pneumoniae forms biofilm-like aggregates in
the lungs. We show that this phenomenon is PsrP-dependent and
mediated by its BR domain. Using recombinant protein and
SRRP mutants, we show that the SRRPs of S. gordonii and
Staphylococcus aureus, GspB and SraP, respectively, also promote
bacterial aggregation, thus describing a previously unrecognized
role for members of the SRRP family. Collectively, these findings
suggest an important dual role for PsrP and other SRRPs during
infection, host cell and intra-species bacterial adhesion, both of
which may be targeted for intervention with antibodies against
recombinant (r)NR.
Results
PsrP promotes pneumococcal aggregation in vivo
To test whether PsrP contributed to biofilm or microcolony
formation in vivo mice were infected with TIGR4 and its isogenic
psrP deficient mutant, T4 DpsrP, and whole lung sections were
examined using scanning electron microscopy (SEM). As would be
expected for both wild type and the mutant, the majority of
bacteria present were in the form of diplococci. However, for
TIGR4 we also observed the presence of large bacterial aggregates
attached to ciliated bronchial epithelial cells as well as to alveolar
epithelial cells (Figure 2). For quantitative analysis of this
phenomenon, nasal lavage fluid and bronchoalveolar lavage
(BAL) fluid from mice was collected two days post-challenge.
Aliquots from each biological sample were heat-fixed to glass
Figure 1. Hypothetical model of PsrP on the surface of S.
pneumoniae. A) Domain structure of PsrP: N-terminal signal peptide
(S); serine-rich repeat motif 1 (SAS[A/E/V]SAST X 11) (SRR1); basic region
(BR); serine-rich repeat motif 2 (SRR2); and the cell wall anchoring
domain (CW) at the C-terminus. B) Illustration of PsrP on the bacterial
surface. Based on the structural organization of PsrP and studies
demonstrating that the BR domain binds to K10 on lung cells [13], we
propose that the CWAD attaches the protein to the cell wall, while the
long glycosylated SRR2 domain serves to extend BR through the
capsular polysaccharide to mediate interactions.
doi:10.1371/journal.ppat.1001044.g001
Author Summary
Serine-rich repeat proteins (SRRPs) are a family of surface-
expressed proteins found in numerous Gram-positive
pathogens, including Staphylococcus aureus, Streptococcus
pneumoniae, Group B streptococci, and the oral strepto-
cocci that cause infective endocarditis. For all of these
bacteria, SRRPs have been demonstrated to play pivotal
roles in adhesion to tissues and the development of
invasive disease. It is now known that biofilm formation is
an important step for bacterial pathogenesis. Bacteria in
biofilms have been shown to have differences in
metabolism, gene expression, and protein production that
contribute to enhanced surface adhesion and the persis-
tence of an infection. Herein we describe a novel role for
PsrP, the S. pneumoniae SRRP, as an intra-species bacterial
adhesin that promotes bacterial aggregation in the lungs
of infected mice during pneumonia. In vitro we show that
the Basic Region domain of PsrP promotes self-interactions
that result in denser biofilms, greater biofilm biomass, and
altered architectures of surface grown cultures; these
interactions could be neutralized by antibodies to PsrP
that are protective against pneumococcal infection. We
also demonstrate that the SRRPs of S. aureus and
Streptococcus gordonii also function as intra-species
bacterial adhesins. Therefore we conclude that SRRPs have
dual roles as host-cell and intra-species bacterial adhesins.
PsrP Mediates Biofilm-Like Aggregates in the Lungs
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slides, Gram-stained, and examined with a microscope (Figure 3A).
In all, the number of bacterial aggregates composed of 2–9, and
$10 diplococci were significantly greater for mice infected with
TIGR4 than T4 DpsrP in both the nasopharyngeal and BAL elute
fluids (Figure 3B,C). Moreover, the largest aggregates, those
composed of .100 bacteria, were observed only in mice infected
with TIGR4. Fluorescent imaging of bacteria in frozen lung
sections confirmed this phenotype; large bacterial aggregates were
only detected in the lungs of TIGR4 infected mice (Figure S1).
Thus we determined that PsrP promoted the formation of biofilm-
like aggregates in vivo, including in the nasopharynx, a site
previously shown not to require PsrP for bacterial colonization
[12].
PsrP affects intimate bacteria to bacteria interactions
Given the previous results, moreover to develop an in vitro model
that was amendable to manipulation, the ability of TIGR4 and T4
DpsrP to form early biofilms was tested using microtiter plates [24].
As shown in Figure 4A, no differences were observed between wild
type and the mutant, suggesting that PsrP does not play a role in
pneumococcal attachment to polystyrene or the formation of early
biofilm structures, in particular the bacteria lawn. The role of PsrP
was next tested in 3-day old mature biofilms using the once-
through continuous flow cells as described previously by Allegrucci
et al. [25]. In this system, a stark difference in the architecture of
TIGR4 and T4 DpsrP biofilms was observed (Figure 4B). Wild type
biofilms displayed a dense cloud-like morphology with extremely
large aggregates that covered the glass surface. Closer inspection
revealed that these aggregates were composed of tightly clustered
pneumococci. In contrast, T4 DpsrP biofilms displayed a less
intimate phenotype characterized by smaller aggregates, gaps, and
the formation of columns, resulting in an overall patchier
phenotype. Quantitative analysis of the biofilm structures using
COMSTAT software confirmed that TIGR4 biofilms had
significantly greater total biomass and average thickness than
those formed by the T4 DpsrP (Figure 4C). No differences in either
the maximum thickness of the biofilms or the roughness coefficient
(a measure of biofilm heterogeneity) were observed (Figure 4C;
data not shown, respectively), indicating that T4 DpsrP could still
form biofilms, although with distinct architecture. Importantly, T4
VpsrP-secY2A2, a mutant deficient in the entire psrP-secY2A2
pathogenicity island, behaved identically to T4 DpsrP, forming
patchy biofilms with small aggregates and less intimate associated
bacteria (Figure S2).
Bacterial biofilms were also grown under once through
conditions in silicone tubing. After a designated time, the biofilms
Figure 2. PsrP promotes the formation of bacterial aggregates in vivo. SEM images of bronchial and alveolar epithelial cells following
infection with TIGR4 (WT) and T4 DpsrP (DpsrP). White arrows point at attached bacteria. Note the presence of WT bacteria in large aggregates of
various sizes.
doi:10.1371/journal.ppat.1001044.g002
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were extruded from the line and examined for biomass both
visually and quantitatively. After 3 days of growth, differences
between TIGR4 and T4 DpsrP in opacity of the exudates were
visible to the eye (Figure 5A) and could be confirmed using a
spectrophotometer which showed a .3-fold difference in optical
density (Figure 5B). Microscopic visualization of the line exudates
following crystal violet (CV) staining revealed that TIGR4 had
formed large aggregates whereas T4 DpsrP exudates were
composed of small clusters or of individual diplococci
(Figure 5C). Increased biofilm biomass was supported by
measurement of total protein concentrations that showed TIGR4
biofilm exudates had 2–3 fold more protein than those
corresponding to T4 DpsrP (Figure 5D).
Of note, during planktonic growth TIGR4, T4 DpsrP, and T4
VpsrP-secy2A2 were indistinguishable, growing either as short
chains or diplococci with a marked absence of aggregates (data not
shown). This led us to examine psrP transcription using Real-Time
PCR and the finding that TIGR4 expressed psrP at levels 47-fold
greater during biofilm versus planktonic culture (P= 0.04 using a
Student’s t-test). Thus low expression of psrP may be one reason
TIGR4 did not form aggregates during liquid culture.
The BR domain mediates intra-species bacterial
interactions
To date a number of groups, including our own, have shown
that SRRPs mediate bacterial adhesion to host cells primarily
through their NR domain [13,26,27]. For this reason we sought to
test whether the BR domain of PsrP was also involved in biofilm/
bacterial aggregation. To do this we first utilized a pre-existing
collection (described in Figure S3) of encapsulated (T4 VpsrP) and
unencapsulated (T4R VpsrP) S. pneumoniae mutants deficient in
PsrP that either expressed a truncated version of PsrP with 33
SRRs in its SRR2 domain (PsrPSRR2(33)), a similar truncated
version lacking the BR domain (PsrPSRR2(33)-BR), or carried the
empty expression vector pNE1 [13]. These strains were tested for
Figure 3. Frequency of bacterial aggregates in the nasopharynx and lungs. A) Micrographs of TIGR4 (WT) and T4 DpsrP (DpsrP) Gram-
stained bacteria from either BAL or nasal lavage (IN) elutes. Images were taken at 4006magnification. Images are not representative of the total
bacteria population, but instead are shown to demonstrate the typical pneumococcal aggregate containing at least 10 or more individual diplococci
(10+). B) Actual percentages of pneumococcal aggregate based on size in the nasopharynx and C) lungs following counting of .100 randomly
selected CFUs per biological replicate. Note that TIGR4 had significantly greater levels of 2–9 and 10+ aggregates compared to T4 DpsrP. Furthermore,
while 10+ aggregates were observed in mice infected with T4 DpsrP, albeit infrequently, the largest of these aggregates were not comparable in size
to those formed by TIGR4. Statistical analyses were performed using a Student’s t-test.
doi:10.1371/journal.ppat.1001044.g003
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their ability to form biofilms in silicone lines under once through
conditions.
Complementation of T4 VpsrP with PsrPSRR2(33), but not
PsrPSRR2(33)-BR or the empty pNE1 vector, partially restored the
ability of T4 VpsrP to form large aggregates in the lines when
examined microscopically (Figure 6A). However, measurement of
other biofilm markers such as optical density and total protein
concentration showed no differences between any of the
complemented mutants and the negative controls (Figure 6B–C).
Complementation of T4R VpsrP with PsrPSRR2(33), also partially
restored the ability of T4R VpsrP to form aggregates (Figure 6A).
In this instance, line exudates from T4R VpsrP with PsrPSRR2(33)
had significant more biofilm biomass than the negative controls
(Figure 6B–C). Importantly, the truncated version of PsrP lacking
the BR domain failed to restore, even partially, T4 VpsrP or T4R
VpsrP suggesting that the BR domain was responsible for the intra-
species aggregation. This was subsequently confirmed by Far-
Western blot analyses that showed that Gst-tagged recombinant
BR (Gst-BR) bound only to S. pneumoniae cell lysates that contained
a truncated PsrP with the BR domain (Figure 6D) and a control
experiment showing that a Gst-tagged Chlamydia trachomatis protein
did not interact with these lysates (Figure S4).
To further explore the role of the BR domain in the observed
bacteria to bacteria interactions, the ability of His-tagged BR
constructs (rBR; Figure 7A), purified from Escherichia coli and Cy3
labeled, were tested for their ability to bind to the surface of
TIGR4 and T4 DpsrP. Full-length rBR interacted with TIGR4 but
not with T4 DpsrP (Figure 7B), confirming not only that PsrP
bound to pneumococci, but also suggesting that its ligand was
another PsrP. Furthermore, only rBR.A retained the ability to
attach to PsrP on the pneumococcal surface. This suggested that
the binding domain of PsrP was possibly located within AA 122–
166, the section not shared between rBR.A and rBR.B.
Hereafter, BR to BR interactions were tested for by Far
Western and co-immunoprecipitation. Far Western blot experi-
ments using assorted E. coli cell lysates from bacteria expressing
assorted rBR constructs, confirmed that only lysates containing
PsrP constructs with AA 122–166 bound successfully to Gst-BR
(Figure 7C). This was also observed in co-immunoprecipitation
experiments, whereby Gst-BR was tested for its ability to bind
whole cell lysates from E. coli expressing versions of PsrP
(Figure 7D). Far Western blots using purified proteins showed
that Gst-BR had affinity to purified rBR, rBR.A, and a synthesized
peptide corresponding to AA 122–166, but not rBR.B, BR.C, or
µ
µ µ µ
Figure 4. Deletion of psrP alters bacterial interactions in mature biofilms but not during early biofilm attachment. A) Attachment of
TIGR4 (WT) and T4 DpsrP (DpsrP) to the bottom of 96-well polystyrene microtiter plate in an early biofilm model. Biofilm biomass was determined
using crystal violet (CV540) stain as described in the methods. B) Micrographs of mature TIGR4 and T4 DpsrP biofilms grown in a flow cell under once-
through flow conditions for 3 days. Bacteria were visualized with Live/Dead BacLight stain using an inverted confocal laser scanning microscope at
4006magnification. C) Quantitative analysis of the biofilms was performed using COMSTAT image analysis software. All experiments were performed
in triplicate. Statistical analyses were performed using a two-tailed Student’s t-test. For panel C error bars denote standard error.
doi:10.1371/journal.ppat.1001044.g004
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the control his-tagged Streptolysin O (Figure 7E). Hence, using
numerous assays it was determined that the BR domain, most
likely AA 122–166, had self-interacting properties that might be
responsible for the observed bacterial aggregation.
Of note, because the BR constructs were purified from E. coli and
PsrP is normally glycosylated, the above observations may have
been an artifact of the unglycosylated constructs used. To address
this possibility a glycosyated truncated PsrP construct was purified
from S. pneumoniae (PsrPSRR2(33)-HIS; Figure S5) and tested for its
ability to bind S. pneumoniae cell lysates containing either native PsrP
or assorted constructs. As shown in Figure 7F, it was determined
that a glycosylated PsrP probe maintained specificity for the BR
domain even in the context of glycosylated recipient protein. A
finding that supports the notion that PsrP to PsrP interactions occur
in natural setting when PsrP is always glycosylated.
The aggregation and K10-binding subdomains of BR are
independent
To determine whether the BR aggregation (AA 122–167) and
the K10 binding subdomains (AA 273–341) of BR had
functionally independent roles, competitive inhibition assays were
performed using rBR constructs. Bacterial adhesion to A549 cells
was tested following incubation of cells with the AA 122–166
peptide, rBR, and rBR.C (Figure 8A). Pre-treatment of A549 cells
with AA 122–167 had no impact on adhesion. In contrast and
consistent with the location of the K10 binding domain within
BR.C: 1) TIGR4 adhered significantly less to cells treated with
rBR or rBR.C, 2) TIGR4 adhered to BSA treated cells better than
T4 DpsrP. In complementary biofilm experiments the opposite
result was observed. Addition of 1 mM peptide AA 122–167 to
media reduced the aggregation phenotype observed for TIGR4
(Figure 8B) and modestly lowered the optical density of the biofilm
exudate and the total biomass collected from the continuous flow
lines versus addition of BR.C (Figure 8C–D). Thus these findings
suggested that the aggregation and K10 subdomains of PsrP had
distinct roles that did not overlap during host cell adhesion or
biofilm formation.
Finally we sought to determine a biological effect for the
aggregation phenotype. We observed that after 1 hour, 6962% of
J477 macrophages incubated with planktonically grown TIGR4
were associated with FITC-labeled bacteria whereas only 5165%
of macrophages mixed with biofilm grown TIGR4 were positive
(P= 0.024). Macrophages exposed to biofilm grown TIGR4 also
took up less bacteria than macrophages mixed with planktonic
(7461%; P=,0.001) and biofilm (6061%; P=,0.001) cultures
of T4 DpsrP. Interestingly, a 10% reduction in macrophage uptake
was observed for the biofilm versus planktonic grown T4 DpsrP
cultures (P= 0.077); and no difference was observed between
macrophage uptake of TIGR4 and T4 DpsrP when taken from
planktonic cultures. These findings suggest, that in addition to
PsrP, other bacterial factors expressed during growth in a biofilm
also affect opsonophagoyctosis.
Antibodies to the BR domain, but not to the SASASAST
motif, block bacterial aggregation
Previously we had shown that antibodies against the SRR1-BR
domains of PsrP neutralized the ability of S. pneumoniae to attach to
lung cells and that vaccination with rBR protected mice against
pneumococcal challenge [12,13]. For this reason we tested the
ability of polyclonal antiserum against rBR and against a SRR
motif peptide to block bacterial aggregation in the biofilm line
model. Todd Hewitt Broth (THB) supplemented with a 1:1000
dilution of antiserum against the BR domain inhibited the
formation of bacterial aggregates as observed by microscopic
visualization of the biofilm line exudates. In contrast, bacteria in
media supplemented with antiserum to the SRR motif peptide or
that from naı¨ve animals, formed aggregates similar to wild type
bacteria grown under serum free conditions (Figure 9A). Biofilm
exudate optical density and protein concentrations supported these
microscopic observations (Figure 9B–C). To determine whether
the effect of the BR antiserum on biofilm formation was specific
for TIGR4, we tested the ability of antibodies to the BR domain to
block biofilm formation in unrelated clinical isolates (Figure S6).
Antiserum against rBR from TIGR4 inhibited biofilm formation
in two unrelated clinical isolates that carried PsrP. The same sera
had no effect on biofilm formation by an invasive serotype 14
isolate that lacked PsrP. Therefore these studies confirmed
previous observations that increased bacteria aggregation in
biofilm models can occur independently of PsrP, but that if
present, antiserum against BR can block the contribution of PsrP
to these processes.
SRRPs mediate intra-species adhesion in pathogenic
bacteria
To determine whether other SRRPs also mediated intra-species
aggregation we tested the effect of gspB and sraP deletion on S.
Figure 5. PsrP promotes bacterial aggregation in a line biofilm
model. Mid-logarithmic growth phase TIGR4 (WT) and T4 DpsrP (DpsrP)
were used to inoculate 1 meter of a 0.8 mm diameter silicone-lined
plastic tubing. After 3 days, biofilms within the lines were extruded. A)
Representative photograph of the exudate suspension immediately
following its collection. B) Optical density (OD540) of bacterial exudates.
C). Microscopic images of CV stained bacteria extracted from the lines.
Note the formation of aggregates by TIGR4 but not T4 DpsrP. D) Levels
of protein in bacteria line exudates as determined by bicinchoninic acid
assay (BCA) following detergent lysis of the bacteria. Images are
representative of at least 3 experiments. Statistical analyses were
performed using a two-tailed Student’s t-test. Error bars denote
standard error.
doi:10.1371/journal.ppat.1001044.g005
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gordonii and S. aureus biofilm architecture, respectively. Deletion of
gspB and sraP negatively impacted biofilm formation in the
microtiter biofilm model at 24 hours (Figure 10A,B). Growth of
wild type and mutant bacteria in the line models also
demonstrated that both proteins contributed to the formation of
large aggregates during surface attached growth; although this
property was much more dramatic for S. gordonii than for S. aureus
which did not show a significant difference in the optical densities
of the exudates (Figure 10C,D). Of note, S. aureus biofilm
experiments were stopped after 1 day due to bacteria overgrowth
and blockage of the lines.
Subsequent Far Western analysis using Gst-BR from S.
pneumoniae as well as recombinant SRR1-NR from SraP and
recombinant NR from GspB showed that these proteins have
affinity for cell lysates from their parent strain but not for cell
lysates from isogenic SRRP deficient mutants (Figure 10E). This
supports the notion that these proteins might be involved in intra-
species aggregation. For PsrP BR from S. pneumoniae, no affinity
was observed for cell lysates from either S. gordonii or S. aureus
suggesting that PsrP does not play a role as an inter-species
adhesin (Figure 10E). In contrast, the NR constructs from S. aureus
and S. gordonii bound to cell lysates from the other bacteria, even in
the absence of the SRRP (Figure 10E). The discrepancy between
PsrP and the other SRRPs might be explained by the fact that
certain SRRPs have been described to have lectin activity [26,27].
In contrast PsrP adhesion has been shown to be independent of
lectin-activity [13].
Discussion
To date, SRRPs have been described in at least 9 Gram-positive
bacteria and have been shown to function as adhesins that
contribute to virulence. For example, deletion of sraP and gspB in
S. aureus and S. gordonii, respectively, decreased the ability of these
bacteria to bind to platelets and form vegetative plaques on heart
valves of catheterized rats [27,28]. Similarly, Srr-1 of Streptococcus
agalactiae has been shown to bind human Keratin 4, mediate
adherence to mucosal epithelial cells, and promote invasion of
bacteria through human brain microvasculature endothelial cells
[29,30]. SRRPs also mediate acellular attachment, a role
Figure 6. The BR domain of PsrP mediates intra-species bacterial interactions. Encapsulated and unencapsulated mutants of TIGR4, lacking
PsrP (T4 VpsrP, T4R VpsrP, respectively), were complemented with plasmids expressing: a truncated version of PsrP having only 33 SRR2 repeats
(PsrP(33)), the truncated version of PsrP missing the BR domain (PsrP(33)-BR), or with the empty expression vector (pNE1). A) Microscopic images of CV
stained bacteria isolated from the line biofilm model. B) Optical density (OD620) of biofilm line exudates. C) Biomass of the biofilms as determined by
protein levels using the BCA assay. D) Far Western analyses of recombinant BR interactions with membrane-bound truncated versions of PsrP
expressed in S. pneumoniae. All images are representative of at least 3 independent experiments. Statistical analyses were performed using 1-Way
ANOVA analysis. Error bars denote standard error. For panel B and C asterisks denote statistical significance versus WT; hash sign denotes statistical
significance versus the empty vector control.
doi:10.1371/journal.ppat.1001044.g006
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important for colonization of the dental surface by oral
streptococci. Froelinger and Fives-Taylor showed that Streptococcus
parasanguis containing mutations of Fap1 failed to attach to saliva-
coated hydroxyapatite [31]. Likewise, deletion of srpA significantly
diminished the ability of Streptococcus cristatus to attach to glass slides
[32]. Thus, while it was well established that SRRPs play an
important role in bacterial attachment to cells or surfaces, until this
report their role as intra-species adhesins remained unrecognized.
A dual role, host and bacterial adhesin for bacterial surface
proteins is not unprecedented. For example, in Streptococcus pyogenes
and S. agalactiae, the pilus proteins mediate adhesion to epithelial
cells and promote microtiter biofilm formation [33,34]. Likewise,
for Neisseria meningitidis, PilX, also a pilus-associated protein,
mediates adhesion to epithelial cells and facilitates bacterial
aggregation [35]. For the pneumococcus, some evidence existed
that bacterial adhesins may also have dual roles. In 2008, Munoz-
Elias et al. found that the pneumococcal adhesins Choline binding
protein A and the pilus protein RrgA were both required for
robust biofilm formation on microtiter plates and efficient
nasopharyngeal colonization [36]. However, the attenuated
biofilm phenotype was observed only with unencapsulated
bacteria and encapsulated mutants formed biofilms normally.
Other pneumococcal proteins shown to affect biofilm formation in
vitro include Neuraminidase A, which possibly alters the extracel-
lular matrix [37,38,39], competence proteins, which suggest an
altered protein profile [40,41], and capsule synthesis enzymes,
which were determined to be down regulated in biofilms
[36,42,43]. Unlike PsrP, which would be expected to bridge cells
directly, these proteins most likely act indirectly by altering gene
expression, the extracellular milieu, or the surface availability of
other adhesins, including possibly RrgA and CbpA.
Our studies determined that the self-aggregating subdomain of
PsrP was located in the BR domain and involves amino acids 122–
166. Recombinant BR constructs containing these amino acids
were able to bind S. pneumoniae carrying PsrP, had an affinity for
the BR domain in other PsrP constructs, and could modestly
inhibit biofilm formation when added to media. Importantly,
adhesion assays using pretreated cells and biofilm assays with
AA 122-395 
AA 122-304 
AA 167-350 
AA 214-395 
+ Cy3 rBR.A + Cy3 rBR.B + Cy3 BR.C + Cy3 rBR 
Figure 7. Recombinant BR interacts with pneumococci that carry amino acids 122–166 of PsrP. A) The designated recombinant PsrP
constructs were expressed and purified from E. coli. B) Micrographs of FITC-labeled bacteria following their incubation with CY3-labeled rBR or the
designated truncated versions. Note that only Cy3-labeled rBR and rBR.A bound to TIGR4. Moreover, neither bound to T4 DpsrP. This suggests that
recombinant BR binds to PsrP on the bacteria surface. C) Far Western blot examining the interaction of Gst-BR with cell lysates from E. coli expressing
assorted rBR constructs spotted on a membrane. D) Co-immunoprecipitation of Gst-BR (65 kDa) from spiked E. coli lysates expressing His-tagged rBR
constructs. E) Far Western blot examining the interaction of Gst-BR with purified rBR constructs and a synthesized peptide corresponding to AA 122–
166. F) Far Western blot examining the interaction of a glycosylated PsrP construct purified from S. pneumoniae, PsrPSRR2(33)-HIS with glycosylated PsrP
constructs expressed in TIGR4.
doi:10.1371/journal.ppat.1001044.g007
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rBR.C showed that the AA 122–166 was not responsible for
adhesion to lung cells and that the K10 binding subdomain (AA
273–341) was not involved in bacterial aggregation. Thus these
subdomains appeared to have independent roles during the
conditions tested. Further studies are warranted to delineate the
specific AAs responsible for these adhesive properties, also to
determine the structure of the BR domain and clarify how these
subdomains interact with PsrP on other pneumococci and K10 on
lung cells.
GspB and SraP have been previously shown to bind platelets
[27,28]. While the ligand for SraP is unknown, it has been
determined that GspB binds to Sialyl T-antigen on platelet
membrane glycoprotein Iba [26,27]. The observation that the NR
domains of GspB and SraP bound to cell lysates containing their
respective SRRPs but not to their mutants and that the mutants
had diminished aggregative properties suggests that SRRPs in
other bacteria might also mediate aggregation in vivo. One could
imagine that SraP on S. aureus or GspB on S. gordonii mediating
attachment to platelets and cells in an endocarditic lesion while at
the same time mediating adhesion of individual bacteria to each
other. Similarly, one could envision a microcolony of the
pneumococcus in the lungs with some bacteria attached to host
cells via PsrP/K10 interactions and other bacteria attached to
these bacteria through PsrP/PsrP interactions. Presumably, this is
what was observed in the lungs of the infected mice. Interestingly,
the finding that GspB and SraP NRs bound to cell lysates from
other bacteria suggests that these proteins may also mediate inter-
species biofilm formation. For S. gordonii, this would be relevant as
the dental plaque is now recognized to be a multi-species biofilm.
Importantly, neutralization of pneumococcal aggregation in
biofilms with BR antiserum suggests that SRRPs might have
utility as vaccine antigens. One caveat is that SRRPs would have
to be one-component of a multi-valent vaccine because not all
strains of S. pneumoniae, S. aureus, or the oral streptococci carry these
proteins.
In previous studies we had found that the length of the SRR2
domain was important for adhesion to K10 when capsule was
present. Consistent with these findings, the inability of truncated
PsrP to fully complement capsulated mutants supports our
hypothetical model that the SRR2 domain serves to extend the
BR domain away from the cell to mediate bacterial interactions.
This model is also indirectly supported by Munoz-Elias et al., who
showed that down-regulation of capsule allowed CbpA and RrgA
to contribute to biofilm production [36]. It is also noteworthy to
state that Munoz-Elias et al. did not identify PsrP in their screen for
biofilm mutants although they used TIGR4 which carries PsrP.
Figure 8. Incubation of bacteria with AA 122–166 impairs bacterial aggregation but not adhesion to cells. A) Adhesion of TIGR4
following pre-incubation of A549 cells with media containing 1.0 mM of the designated rBR constructs. All values were normalized against cells
incubated with BSA (16364 bacteria/106 cells). TIGR4 in media containing 1 mM BR.C or the synthesized peptide 122–126 was used to inoculate and
grow biofilms in the line biofilm model. After 3 days, biofilms within the lines were extruded. B) Representative photograph of the exudate
suspension immediately following its collection and staining with CV. Images are representative of at least 3 experiments. C) Optical density (OD540)
of bacterial exudates. D) Levels of protein in bacteria line exudates. Statistical analyses were performed using a Student’s t-test. Error bars denote
standard error.
doi:10.1371/journal.ppat.1001044.g008
PsrP Mediates Biofilm-Like Aggregates in the Lungs
PLoS Pathogens | www.plospathogens.org 9 August 2010 | Volume 6 | Issue 8 | e1001044
This can be explained by the fact that we observed no contribution
for PsrP in the microtiter plate early biofilm model.
We observed that PsrP-mediated bacterial aggregation occurred
in the nasopharynx, despite earlier studies demonstrating that K10
was absent from this site and that PsrP was not required for
nasopharyngeal colonization. Aggregation of S. pneumoniae in the
nasopharynx may serve as a mechanism to resist opsonophago-
cytosis as shown herein, or we speculate a way to resist desiccation
during transmission of infectious particles. The observation that
aggregates were present at an anatomical site that lacked K10,
further supports an independent role for these PsrP subdomains.
In regards to opsonophagoyctosis, one important consideration is
that the pneumococcus most likely has different gene expression
profiles in vivo as an aggregate attached to a cell versus in vitro as
a biofilm [44]. Thus caution is warranted in applying our vitro
observations, such as resistance to opsonophagoyctosis or
enhanced PsrP expression during biofilm growth, with events that
occur in vivo.
Polyclonal antibodies against the BR domain, but not the SRR
motif, neutralized the ability of TIGR4 and clinical isolates
carrying PsrP to form aggregates in the line model. These findings
were consistent with previous studies showing that antibodies
against BR also neutralized its ability to mediate adhesion to host
cells and protected mice against pneumonia [12,13]. One possible
reason that antibodies against the SRR motif peptide failed to
have a neutralizing effect is that PsrP is glycosylated and antibodies
against the peptide failed to recognize the native version of the
protein. Alternatively, antibodies to the SRR motif may bind away
from the BR domain and therefore do not inhibit the ability of the
BR domain to self-interact. Interestingly, polyclonal antibodies to
surface proteins often promote aggregation. This did not occur for
unknown reasons. Finally, our finding that antibodies against rBR
neutralized bacterial aggregation in the biofilm line model suggests
that the same antibodies might also neutralize bacterial aggrega-
tion in vivo. This remains to be tested, however, the protection that
was observed in mice following immunization with rBR [13], may
have been in part due to inhibition of bacterial aggregation in
addition to blocking interactions with K10.
Importantly, because rNR domains produced in E. coli are not
glycosylated, yet for the tested SRRPs were able to aggregate,
immunoprecipitate, and bind to native protein in cell lysates, it
seems that the BR domain does not require glycosylation to
function as a self-adhesin. This is supported by the observation
that addition of antibodies against unglycosylated rBR and that
synthetic peptide AA 122–166 both inhibited bacterial aggregation
in the biofilm line. In contrast to the latter concept, Wu et al.
demonstrated that monoclonal antibodies specific for the glycan
motifs of the serine-rich repeat motifs of Fap1 were capable of
blocking attachment to saliva coated hydroxyapatite by Streptococcus
parasanguis [45]. Importantly, Fap1 is the most divergent of the
SRRPs and has 2 NR domains. Fap1 adhesion to saliva coated
hydroxyapatite is mediated by glyconjugates on the serine-rich
repeat domain [46]; as evidenced by the fact that inactivation of
one of the glycosyltranferases known to modify the glycan moieties
of Fap1, drastically altered the ability of S. parasanguis to form
biofilms [45]. Thus Fap1 is interesting because it suggests an NR-
independent mechanism for SRRP adhesion, which is distinct
from those discussed for GspB, SraP, or PsrP. Future studies need
to further examine the differences between these diverse SRRPs
and to determine if the two NRs of Fap1 play a role in bacterial
aggregation. This is especially true given that the NR domain of
SraP has a pI of 5.6, in contrast to the basic NRs of GspB (9.5 pI)
and PsrP (9.9 pI) [47].
In summary, we have described for the first time the presence
of a pneumococcal biofilm-like structure in the lungs of infected
mice. We have determined that PsrP mediates a more intimate
bacterium to bacterium interaction that contributes to the
presence of large bacteria aggregates in vivo and increased biofilm
biomass and aggregates in vitro. This property appears to be
shared among other SRRPs including those of medically relevant
bacteria such as S. aureus and S. gordonii, suggesting that it is a
conserved function for this class of proteins. How these
interactions contribute to pathogenesis remains to be fully
determined, however, studies with other bacteria indicate that
biofilms serve to inhibit phagocytosis, protect against defensin-
mediated killing, and serve as a focal point of infection during
early stages of disease. Future experiments will be required to
determine the extent to which this may apply for SRRP-mediated
aggregates in vivo.
Methods
Bacterial strains and media
Wild type strains used in this study included S. pneumoniae strain
TIGR4 and the previously described clinical isolates IPD-5,
TNE-6012, and TBE-6050 [8,12,14]. T4R is an unencapsulated
derivative of TIGR4 [48]. S. aureus ISP479C and S. gordonii M99
and their corresponding isogenic mutants ISP479C DsraP, and
Figure 9. Antibodies to the BR domain but not the serine-rich
motif block intra-species bacterial interactions. THB was
supplemented with either a 1:1000 dilution of naı¨ve rabbit serum
(control), rabbit antiserum from rabbits immunized with a SASASAST-
SASASAST peptide designed after the SRR motif, or rabbit antiserum to
recombinant BR. A) Micrographs of CV stained bacteria extruded from
the biofilm lines. B) Optical density of bacterial exudates. C) Levels of
protein in bacterial line exudates as determined by BCA analysis. Images
are representative of at least 3 independent experiments. Statistical
analyses were performed using a two-tailed Student’s t-test. Number
sign denotes statistical significance versus whole serum. Asterisks
denote statistical significance versus anti-SRR serum. Error bars denote
standard error.
doi:10.1371/journal.ppat.1001044.g009
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M99 DgspB have also been previously described [17,27]. All of
the S. pneumoniae mutants used in this study including T4 DpsrP,
T4 VpsrP-secY2A2, T4 VpsrP, and T4R VpsrP have been shown
not to have polar effects on upstream and downstream gene
transcription [12,13]. S. pneumoniae and S. gordonii were grown in
Todd-Hewitt broth (THB) or on blood agar plates at 37uC in 5%
CO2. S. aureus were grown in Tryptic-Soy Broth (TSB) or on
blood agar plates at 37uC. Stocks for the PsrP mutants were
grown in media supplemented with 1 mg/mL of erythromycin,
those complemented with the expression vector pNE1 were
grown on media supplemented with 250 mg/mL of spectinomy-
cin. SraP and GspB mutant stocks were grown in media
supplemented with either 15 mg/mL of erythromycin or 5 mg/
mL chloramphenicol respectively. E. coli strain DH5a (Invitrogen,
Carlsbad CA) expressing recombinant PsrP constructs were
grown with 50 mg/mL of kanamycin. Recombinant proteins
were purified as previously described [13,26]. To avoid stress
effects on the bacteria, no antibiotics were added to the media
during any of the experiments.
Infection of mice and collection of tissues
Female BALB/cJ mice, 5–6 weeks old, were obtained from The
Jackson Laboratory (Bar Harbor, ME). Mice were anesthetized with
2.5% vaporized isoflurane prior to challenge. Exponential phase
cultures of S. pneumoniae were centrifuged, washed, and suspended in
sterile phosphate buffered saline (PBS). For each experimental cohort
at least 6 mice were instilled with either 107 cfu of TIGR4 or T4DpsrP
in 20 mL of PBS into the left nostril. After two days mice were
sacrificed for tissue collection. For imaging experiments the intact
lungs were collected and processed as described below. For
enumeration of bacterial aggregates, nasal lavage fluid was collected
from anesthetized mice by instillation and retraction of 20 ml PBS.
The same mice were subsequently asphyxiated with compressed CO2,
and BAL fluid collected by flushing the lungs twice with 0.5 ml of PBS
using a sterile catheter. All animal experimentation was conducted
following the National Institutes for Health guidelines for housing and
care of laboratory animals. Animal experiments were reviewed and
approved by the Institutional Animal Care and Use Committee at
The University of Texas Health Science Center at San Antonio.
Figure 10. The SRRPs of S. gordonii and S. aureus promote bacterial aggregation. Light microscopic images of CV stained A) S. gordonii M99
and B) S. aureus ISP479C and their respective isogenic SRRP mutants following 24 hours of growth in a 96-well polystyrene microtiter plate early
biofilm model. B) Average biomass of early biofilms as determined by CV540 analyses. Error bars denote standard deviation. C) Microscopic images of
bacteria extruded from the biofilm lines after 3 days for S. gordonii and 1 day for S. aureus. D) Measurement of optical density of bacterial exudates
collected from the biofilm lines. Error bars denote standard deviation. E) Far-western examining the intra- and inter-species specificity of the NR
domains of S. pneumoniae, S. gordonii and S. aureus. Whole cell lysates from S. gordonii, S. aureus, and their respective isogenic SRRP mutants were
spotted onto nitrocellulose membranes and probed with these GST-tagged proteins. Images are representative of three individual experiments. For
panels B) and D) statistical analyses were performed using a Student’s t-test.
doi:10.1371/journal.ppat.1001044.g010
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Scanning electron microscopy (SEM)
Lungs were cut in a sagital orientation, fixed for 2 hours with
2.5% glutaraldehyde in PBS, and then rinsed twice for 3 min in
0.1 M phosphate buffer (pH 7.4). Lungs were submerged in 1%
osmium diluted in Zetterquist’s Buffer for 30 minutes then washed
with the same buffer for 2 minutes [49]. This was followed by step-
wise dehydration with ethanol (i.e. 70%, 95%, and 100%); the first
two steps for 15 minutes, the last for 30 minutes. Samples were
treated with hexamethyldisilizane for 5 minutes prior to drying in
a desiccator overnight. The next day samples were sputter coated
with gold palladium and viewed with a JEOL-6610 scanning
electron microscope.
Visualization of bacterial aggregates ex vivo
From each mouse BAL and 1:10 PBS diluted nasopharyngeal
lavage elutes were smeared onto glass slides, heat fixed, and Gram-
stained. Since the nasopharyngeal samples were mucoid, dilution
of the samples was warranted. Bacteria were visualized using a
CKX41 Olympus microscope at 2006 magnification. For each
biological sample 100 CFU were randomly selected, taking note of
the approximate number of diplococci composing each CFU,
either 1, 2–10, or .10. Images of the bacteria were acquired at
4006 magnification to better show the multiple bacteria
composing the aggregates.
Fluorescent microscopy of tissue sections
Lung tissues were excised and frozen in Tissue Tek O.C.T
solution (Miles Scientific). 5 mm thick lung sections were cut at the
University of Texas at San Antonio Histopathology Core and
stored at 280u C. Bacteria in the lung sections were detected by
immunofluorescence using antibody against the capsular polysac-
charide. Sections were thawed, fixed with ice-cold acetone for
20 minutes, and then rehydrated with 70% ethyl alcohol and then
PBS. Samples were permeabilized with 0.1% Triton-X-100 for
5 minutes then blocked with 10% fetal bovine serum (FBS) in F12
media for 1 hour. Sections were incubated with 1:1,000 rabbit
anti-serotype 4 pneumococcus antiserum (Statens Serum Institut,
Denmark) overnight at 4uC. After washing for three times with
0.5% Tween-PBS, sections were covered with FBS-F12 containing
goat anti-rabbit FITC conjugated antibody (Invitrogen) at 1:2,000
and DAPI (5 mg/ml; for DNA) and the sections incubated for
1 hour at room temperature. Tissue sections were washed and
mounted with FluorSave (Merck Biosciences). Images were
acquired at 1,0006using a Nikon AX-70 fluorescent Microscope
and images processed with SimplePCI software.
Visualization of early and mature biofilms
Early biofilm formation was examined by measuring the ability
of cells to adhere and accumulate biomass on the bottom of a 96-
well (flat-bottom) polystyrene plates (Costar, Corning Incorporat-
ed, Lowell MA) [24]. Microtiter wells with 200 ml THB were
inoculated with 106 CFU of S. pneumoniae taken from cultures at
mid-logarithmic phase growth (OD620 = 0.5). Plates were incubat-
ed at 37u C in 5% CO2. S. aureus and S. gordonii biofilm formation
on microtiter plates was done in a similar manner, with the
exception that TSB was used for S. aureus [50,51]. Bacteria were
grown for 2, 4, 6, 8, 18, and 24 h, after which the biofilms were
washed gently with PBS and stained with 100 mL of 0.1% CV.
Biofilm biomass was subsequently quantified by image capture
using an inverted microscope at 156and 1006magnification and
measuring the corresponding optical density (A540) of the
supernatant following washing of the bacteria and solubilization
of CV in 200 mL of 95% ethanol.
Mature S. pneumoniae biofilms were grown under once through
conditions in a glass slide chamber using a continuous-flow
through reactor [25]. The flow cell was constructed of anodized
aluminum containing a chamber (4.0 mm by 1.3 cm by 5.0 cm)
having two glass surfaces, one being a microscope slide and the
other being a glass coverslip serving as the substratum. S.
pneumoniae cells grown to mid-logarithmic phase served as the
inoculum and were injected into a septum 4 cm upstream from the
flow cell. Bacteria were allowed to attach to the glass substratum
for 2 hours prior to initiating flow. The flow rate of the system was
adjusted to 0.014 ml/min. Flow through the chamber was
laminar, with a Reynolds number of ,0.5, having a fluid
residence time of 180 min. Biofilms were grown at 37uC in 5%
CO2 for 3 days under once through conditions. Biofilms were then
visualized by confocal laser microscopy as described below.
Biofilms were also grown on the interior surface of a 1-meter
long, size 16 Masterflex silicone tubing (0.89mm Internal
Diameter, Cole Parmer Inc.) using once-through continuous flow
conditions. The line was inoculated with 5 mL of a mid-
logarithmic culture and the bacteria were allowed to attach for
2 hours. The flow rate of the system was adjusted to 0.035 ml/min
and bacteria were grown for 3 days at 37uC in 5% CO2. Bacterial
cells were harvested from the interior surface by pinching the tube
along its entire length, resulting in removal of the cell material
from the lumen of the tubing. Following extraction, exudates were
gently suspended in 1 ml of PBS and the optical density (OD620)
was measured. For light microscopy pictures, 50 ml of line exudate
in saline was stained by the addition of 50 mL of 1% CV. A
volume of 5 ml of stained line exudates was applied to glass slides,
coverslipped, and images taken at 2006 magnification using a
light microscope. Viable cell counts were determined by plating
serial dilutions of exudates following the disruption of each sample
by vortexing. Biofilm biomass was determined by measuring the
total protein concentration of the exudates by BCA following the
complete lysis of S. pneumoniae with saline containing 0.1%
deoxycholate and 0.1% sodium-dodecyl sulfate, which activates
the murein hydrolase autolysin, or use of French press for S.
gordonii and S. aureus cultures. For studies testing whether
antibodies or recombinant protein inhibited bacteria aggregation
media was supplemented with BR antiserum at 1:1,000 or spiked
with recombinant protein at a final concentration of 1.0 mM.
Confocal scanning laser microscopy and image
acquisition
Confocal scanning laser microscopy was performed with an
LSM 510 Meta inverted microscope (Zeiss, Heidelberg, Ger-
many). Images were obtained with an LD-Apochrome 406/0.6
lens and the LSM 510 Meta image acquisition software (Zeiss). To
visualize the biofilm architecture of 3-day-old biofilms, biofilms
were stained using the Live/Dead BacLight stain from Invitrogen
(Carlsbad, CA). Quantitative analysis of epifluorescence micro-
scopic images obtained from flow cell-grown biofilms at the 6-day
time point was performed with COMSTAT image analysis
software [52].
Far Western analysis of BR interactions
Recombinant full-length BR and truncated versions (BR.A,
BR.B, BR.C) were expressed and purified from E. coli as previously
described [13]. Glycosylated PsrPSRR2(33)-HIS was purified in the
same manner from TIGR4 (Figure S3), with the exception that
cultures were induced with 1% fucose and lysed with 1% SDS in
PBS. Far Western analysis was carried out as described by
Takamatsu et al. with minor modifications [53]. Nitrocellulose
membranes were spotted with either 1 mg of whole cell lysate of S.
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pneumoniae, S. gordonii, S. aureus or E. coli expressing various PsrP
constructs or with purified recombinant proteins in PBS.
Membranes were incubated overnight in PBS with 4% bovine
serum albumin and 0.1% Tween 20 (T-PBS) at room temperature.
The next day, membranes were washed with T-PBS three times
for 5 minutes, and incubated overnight at 4uC on an orbital
platform rocker with T-PBS containing 1% bovine serum albumin
(TB-PBS) with 1 mg/mL of Gst-BR, PsrPSRR2(33)-HIS, or the
designated NR constructs from S. gordonii and S. aureus.
Membranes were washed and incubated with monoclonal mouse
anti-Gst antibody (1:5,000 dilution) (Proto-Tech) overnight at 4uC
in TB-PBS. Antibody binding was detected by incubating the
membranes for 1 h with HRP-conjugated anti-mouse IgG
(1:10,000 dilution) (Sigma), followed by development with the
Super Signal chemiluminescent detection system (Thermo Scien-
tific). As a control for inadvertent interactions with the Gst tag, Far
Western blots were also performed using an unrelated Gst-tagged
Chlamydia trachomatis protein (TC0109; Figure S4). No interactions
were observed.
Co-immunoprecipitation of Gst-BR with rBR
Co-immunoprecipitation of Gst-BR with the truncated versions
of rPsrP was carried out as previously described by Shivshankar et
al. [13]. Protein G Sepharose beads (Amersham) were incubated
overnight at 4uC with mouse monoclonal penta-His antibody
(1:50; Qiagen) in 500 ml of F12 media supplemented with 10%
fetal bovine serum. Beads were incubated with 400 ml of whole
bacterial lysates from E. coli expressing penta-His tagged
recombinant versions of PsrP spiked with 200 mg of recombinant
Gst-BR full length and incubated overnight at 4uC with gentle
agitation. Beads were washed with RIPA buffer, then boiled in
sample buffer for 10 min [54]. Samples were separated on 12%
SDS-PAGE gels and electrophoretically transferred to nitrocellu-
lose membranes. Membranes were blocked with T-PBS containing
4% bovine serum for 30 min at room temperature. Membranes
were then incubated overnight at 4uC with mouse anti-Gst
(1:7500; Proto-tech) in blocking buffer. Following incubation,
membranes were washed with T-PBS three times for 5 minutes.
HRP-conjugated goat anti-rabbit Immunoglobulin G (1:10 000;
Sigma) was used as the secondary antibody, followed by
development with the Super Signal chemiluminescent detection
system (Thermo Scientific).
Visualization of recombinant BR bound to TIGR4
For labeling of bacteria, TIGR4 and T4 DpsrP were pelleted
and suspended in 1 ml of carbonate buffer (pH 9.0) containing
FITC (1 mg/ml) and incubated in the dark at room temperature
with constant end-to-end tumbling. FITC-labeled bacteria were
washed with PBS (pH 7.4) and centrifuged, until the supernatant
became clear. rBR fragments were labeled using a FluorLink-Ab
Cy3 labeling kit (Amersham) using the instructions provided by the
manufacturer. Labeled bacteria were suspended in serum-free F12
media containing the labeled constructs for 1 hour and gently
mixed. Subsequently, pneumococci were washed and suspended in
F12 medium. Labeled bacteria and bound recombinant protein
were visualized using an AX-70 fluorescent microscope and the
images were captured at 0.1112–0.8886 ms exposure time for Cy2
and Cy3 filters. The magnification used for capture of digital
images was 10006. Captured images were processed using Simple
PCI software.
Adhesion assays
A549 cells (human alveolar type II pneumocytes; ATCC CRL-
185), were grown to 90% confluence on 24-well plates (,106 cells/
well). Prior to use, cells were washed with cell F12 media to
remove serum. For competitive inhibition binding assays, A549
cells were incubated with 1mM of either rBR, rBR.C, a synthesized
peptide corresponding to AA 122–167, or BSA for 1 HR.
Following incubation, cells were exposed to media that contained
107 cfu/mL of bacteria and incubated for 1 h at 37uC in 5% CO2.
Nonadhering bacteria were removed by washing the cells 3 times
with T-PBS and the number of adhering bacteria was determined
by lysis of the monolayer with 0.1% Triton X-100 and plating
wells per experiment.
Opsonophagocytosis assay
Bacterial cultures were centrifuged and suspended in 0.1M
sodium carbonate buffer (pH 8.0) at an OD620 of 0.2. Care was
taken to cause minimal disruption of the biofilm aggregates. The
diluted cultures were labeled with fluorescent isothiocyanate
(1mg/ml) for 30 min at room temperature in the dark. Following
labeling, cultures were gently washed three times with sterile PBS
to remove free FITC and suspended in PBS. FITC-labeled
bacteria were opsonized with 3% control rabbit serum for
30 minutes at 37uC with mild periodical tapping. Mouse J774.1,
macrophage cultures maintained in 10% FBS containing DMEM
were used for phagocytosis of the opsonized pneumococci.
Macrophages were harvested, washed and diluted with opsono-
phagocytosis buffer (PBS containing 0.2% BSA). FITC-labeled
bacteria in 100 ml were added to 106 macrophage cells in 400 ml
and incubated for 1 hour at 37uC with periodic shaking.
Afterwards, the macrophages were pelleted and washed twice in
the assay buffer. Cells were suspended in 400ml of 2%
paraformaldehyde until flow cytometric analysis. A2-Laser BD
FACSCaliber Analyzer (Becton Dickinson, NJ; Institutional Flow
Cytometry Core Facility at the Health Science Center) was
employed to analyze percent phagocytic uptake of the labeled
bacteria by the macrophages. A minimum of 20,000 events were
counted for each sample at 480 nm excitation and 530nm
detection wavelengths. Background fluorescence was nullified by
subjecting negative control macrophages in assay buffer without
any fluorescent bacteria to FACS analysis. Data were processed
using CellQuest software.
Statistical analysis
For pair-wise comparisons of groups statistical analyses were
performed using a Student’s t-test. For multivariate analyses a 1-
Way ANOVA followed by a post-priori test using Sigma Stat
software was used.
Supporting Information
Figure S1 Immunofluorescent imaging of S. pneumoniae in the
alveolar space. Frozen lung sections from TIGR4 and T4 DpsrP
infected mice were processed for imaging using anti-serotype 4
capsular antiserum (Statens Serum Institute; Denmark). Images
were taken at 6006and are representative. Note the detection of a
large bacterial aggregate (green) for TIGR4 infected animals,
whereas for mice infected with T4 DpsrP smaller clusters are
evident.
Found at: doi:10.1371/journal.ppat.1001044.s001 (0.12 MB PDF)
Figure S2 Deletion of psrP-secY2A2 alters bacteria interactions in
mature biofilms. A) Micrographs of mature TIGR4 and T4 VpsrP-
secY2A2 biofilms. Bacteria were grown in THB at 37u C in 5%
CO2 on glass slides within a flow cell under once-through flow
conditions for 3 days. For visualization, bacteria were stained with
Live/Dead BacLight stain. Biofilms were viewed at 4006
magnification using an inverted confocal laser scanning micro-
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scope. B) Quantitative analysis of biofilms was performed using
COMSTAT image analysis software. Flow cell experiments were
performed in triplicate. Statistical analyses were performed using a
two-tailed Student’s t-test. For panel C error bars denote standard
error.
Found at: doi:10.1371/journal.ppat.1001044.s002 (0.26 MB PDF)
Figure S3 Illustration of the psrP loci in TIGR4 & T4R, T4
VpsrP & T4R VpsrP, and assorted pNE1 plasmids encoding
truncated versions of psrP.
Found at: doi:10.1371/journal.ppat.1001044.s003 (0.08 MB PDF)
Figure S4 Far Western analyses using a GST tagged protein
(TC0109) from Chlamydia trachomatis as a probe for non-specific
interactions due to the Gst-tag. Membranes were spotted with
either A) lysates from S. pneumoniae expressing truncated versions of
PsrP; B) truncated versions of His tagged rBR expressed and
purified from E. coli; or C) whole cell lysates from S. gordonii, S.
aureus, S. pneumoniae and their respective isogenic SRRP mutants.
Found at: doi:10.1371/journal.ppat.1001044.s004 (0.22 MB PDF)
Figure S5 Purification of a glycosylated PsrP construct. A)
Illustration of the psrPSRR2(33)-HIS locus in the expression vector
pNE1. The plasmid was used to express and purify glycosylated
PsrP from S. pneumoniae, strain TIGR4 cell lysates. Note the
presence of fcsRK, a pneumococcal fucose-inducible promoter, also
that the cell wall anchor domain has been replaced with a 66
histidine tag. B) Western blot of glycosylated PsrPSRR2(33)-HIS in
TIGR4 following induction with 1% fucose. Despite having a
predicted mass of 66 kDa PsrPSRR2(33)-HIS separates at an
apparent molecular mass of 200 kDa. This is due to glycosylation
and these findings are consistent with earlier work by Shivshankar
et al. [13].
Found at: doi:10.1371/journal.ppat.1001044.s005 (0.08 MB PDF)
Figure S6 Antiserum against TIGR4 BR inhibits biofilm
formation of unrelated clinical isolates that carry PsrP. Low
passage clinical isolates of S. pneumoniae carrying PsrP (TNE-6050,
TNE 6012) or without (IPD-5), were grown in silicone coated lines
under once-through conditions at 37uC in 5% CO2 for 3 days.
THB was supplemented with either naı¨ve rabbit serum (control) or
antiserum to recombinant TIGR4 BR at a dilution of 1:1000.
Following incubation, biofilms were extruded and analyzed. A)
Micrographs of CV stained bacteria extruded from the biofilm
lines. B) Optical density (OD540) of bacterial exudates. C) Levels of
protein in bacteria line exudates as determined by BCA analysis.
Note that antiserum against BR did not affect biofilm formation by
IPD-5, the PsrP deficient clinical isolate. Images are representative
of at least 3 independent experiments. Statistical analyses were
performed using a two-tailed Student’s t-test. Error bars denote
standard error. Asterisks denote statistical significance versus
whole sera.
Found at: doi:10.1371/journal.ppat.1001044.s006 (0.26 MB
PDF)
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